What top creators are saying about Evolus, Inc.(EOLS)
A medical aesthetics company with an anti-wrinkle injection product (Jeuveau) that competes with Botox.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about Evolus, Inc. in the last 30 days yet.
Top creators covering Evolus, Inc. (EOLS)
The 1 sources with the most insights about Evolus, Inc. on Kazuha.
Latest insights about Evolus, Inc. (EOLS)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Wednesday, July 9, 2025
Called the cheapest, high-growth stock in the group, it is a disruptor with 32% revenue growth, a cheap valuation, and a major catalyst with its upcoming launch of a synergistic filler product line.
Wednesday, July 9, 2025
Called the cheapest, high-growth stock in the group, it is a disruptor with 32% revenue growth, a cheap valuation, and a major catalyst with its upcoming launch of a synergistic filler product line.
Discussed alongside Evolus, Inc. (EOLS)
Other assets that creators frequently mention in the same content as Evolus, Inc..
Frequently asked
Which podcasters and creators cover Evolus, Inc. (EOLS) the most?
The most active sources covering Evolus, Inc. (EOLS) on Kazuha are @BeatTheDenominator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Evolus, Inc. (EOLS) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Evolus, Inc. (EOLS) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Evolus, Inc. (EOLS)?
Creators covering Evolus, Inc. (EOLS) most frequently also discuss OLPX, ELF, ODD, AIRS, INMD. See the "Discussed alongside" section above for full asset pages.